J-PHARMA CO., LTD.
8Patents
5Active
8Granted
38Portfolio score
Filing activity: Sep 20, 1999 → Nov 7, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9618512B2 | Biomarker for breast cancer | Chemistry; Metallurgy | 5 | Active |
| US10005750B2 | Developing potent urate transporter inhibitors: compounds designed for their uricosuric action | Chemistry; Metallurgy | 2 | Active |
| US10172835B2 | Anticancer agent composition | Chemistry; Metallurgy | 1 | Active |
| US8039586B1 | Cerebral organic anion transporter and its gene | Chemistry; Metallurgy | 0 | Expired |
| US11899019B2 | Method for predicting efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy, method for evaluating cancer grade, and method for enhancing efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy | Physics | 0 | Active |
| US10173990B2 | URAT1 inhibitor | Chemistry; Metallurgy | 0 | Active |
| US7666999B2 | Neutral amino acid transporter and gene thereof | Human Necessities | 0 | Expired |
| US7419790B2 | Sodium-independent transporter carrying acidic amino acid and its gene | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.